Division of Infectious Diseases

 

The Division of Infectious Diseases' mission is to provide high-quality consultative services to prevent, diagnose and manage infectious complications in patients (adult and pediatric) undergoing cancer treatment. We provide specialized expertise to treat complex infectious complications in our patients undergoing chemotherapy or immunotherapy, stem cell transplantation, CAR T cellular therapies and complex oncologic surgeries. Our service provides access to up-to-date treatment options and experimental therapies for infectious complications (bacterial, viral, fungal, parasitic) that may not have the standard therapeutic intervention available. This is complemented by high-quality infection control and the availability of therapeutic clinical trials. Our clinical team is instrumental in developing clinical pathways/standard operating procedures for managing infections in various treatment settings, such as sepsis management in our evaluation and treatment center and the hospital. We provide vital services to the institution, such as infection control and antimicrobial stewardship expertise to meet and exceed the stringent regulatory requirements.

As a part of a multidisciplinary team including hematologists and pharmacists, our Infectious Diseases faculty develops and updates clinical pathways for the hematopoietic cell transplant (HCT) program as mandated by the Foundation for the Accreditation of Cellular Therapies. The division maintains a robust clinical research program and participates in translational research. Our education programs include the training of rotating Accreditation Council for Graduate Medical Education-accredited infectious disease fellows from the Naval Medical Center, training for hematology and HCT nurse practitioners, and a program enabling students to shadow research or clinical personnel.